drugset / Trial / NCT03473561

Study to Evaluate the Efficacy and Safety of Racecadotril in Children Aged 3 to 60 Months Suffering From Acute Diarrhea

NCT03473561 ↗

Phase 3 Completed 31 enrolled Abbott
NaSingle-groupOpen-labelTreatment

Summary

This is a prospective, open-label, multicenter, single-arm study evaluating the efficacy and safety of Racecadotril the treatment of children aged 3 to 60 months suffering from acute diarrhea

Timeline

Start
2018-08-25
Primary completion
2020-01-08
Completion
2020-01-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Racecadotril Small molecule 1.5 mg/kg Oral

Indications